# Evaluating Crosslinked Hyaluronate Canalicular Gel for the Treatment of DED in Patients Undergoing Cataract Surgery

> **NCT07155057** · NA · RECRUITING · sponsor: **Vance Thompson Vision** · enrollment: 60 (estimated)

## Conditions studied

- Dry Eye Disease (DED)

## Interventions

- **DEVICE:** Cross-Linked Hyaluronate Gel Prefilled Syringe 30 MG/3ML

## Key facts

- **NCT ID:** NCT07155057
- **Lead sponsor:** Vance Thompson Vision
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-03
- **Primary completion:** 2026-06
- **Final completion:** 2026-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07155057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07155057, "Evaluating Crosslinked Hyaluronate Canalicular Gel for the Treatment of DED in Patients Undergoing Cataract Surgery". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07155057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*